The F.D.A. announced Monday that it would change the drug’s label to reflect potential benefits in reducing autism symptoms. By Christina Caron Dr. Marty Makary, the commissioner of the Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback